How the New 510(k) Ruling is Affecting Manufacturers
According to RAPS, the new 510(k) ruling by FDA details “how regulators will evaluate applications in order to determine ‘substantial equivalence.'” In the past, medical device manufacturers were able to reference separate but similar devices or products (called predicate devices) that had already been marketed in order to assess the safety of their new device. Read more »